NASDAQ Primary Care Market News

Cempra’s Fusidic Acid Achieves Primary Endpoint in Phase 3 Study of ABSSSI

—Fusidic acid met primary endpoint and secondary efficacy endpoints— —Fusidic acid well tolerated in ...

Cempra’s Fusidic Acid Achieves Primary Endpoint in Phase 3 Study of ABSSSI

—Fusidic acid met primary endpoint and secondary efficacy endpoints— —Fusidic acid well tolerated in ...